Related Experiment Videos
Type IV Ehlers-Danlos syndrome with platelet delta-storage pool disease
I Español1, A Hernández, R M Pujol
1Departament d'Hematologia, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma, Barcelona, Spain.
Insights
This report details a rare case of Ehlers-Danlos syndrome type IV combined with platelet delta-storage pool disease. Desmopressin acetate (DDAVP) successfully corrected platelet aggregation abnormalities.
Area of Science:
- Hematology
- Genetics
- Connective Tissue Diseases
Background:
- Ehlers-Danlos syndrome (EDS) is a group of inherited connective tissue disorders.
- Type IV EDS, also known as vascular EDS, is characterized by a high risk of arterial or visceral rupture.
- Platelet delta-storage pool disease involves defects in platelet dense granules, affecting hemostasis.
Observation:
- A patient presented with clinical features consistent with type IV Ehlers-Danlos syndrome.
- Ultrastructural examination revealed a deficiency in platelet dense granules, with decreased numbers and altered electron-dense material.
- Platelet aggregation studies showed impaired responses to ristocetin and arachidonic acid.
Findings:
- The study reports a co-occurrence of type IV Ehlers-Danlos syndrome and partial platelet delta-storage pool disease.
- Ultrastructural analysis confirmed reduced and abnormal platelet dense bodies.
- Impaired platelet aggregation was observed, indicating functional deficits.
Implications:
- This case highlights a potential link between vascular EDS and platelet dense granule defects.
- The findings suggest that desmopressin acetate (DDAVP) may be a therapeutic option for managing bleeding complications in such patients.
- Further research is warranted to explore the underlying mechanisms and prevalence of this dual diagnosis.
Abstract:
A case of type IV Ehlers-Danlos syndrome with a partial platelet delta-storage pool disease is reported. The diagnosis of Ehlers-Danlos was clinical. The platelet-dense granule deficiency was determined by ultrastructural platelet morphology. Dense bodies were decreased in number, and most showed loss or fragmentation of electron-dense material. Aggregation studies revealed a retarded response to ristocetin and arachidonic acid, which was corrected with desmopressin acetate-DDAVP.